tiprankstipranks
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market

Ocular Therapeutix (OCUL) Ownership - Who Owns Ocular Therapeutix?

Compare
1,411 Followers

Ocular Therapeutix (OCUL) Ownership Overview

8.84%9.75%49.32%11.35%20.74%
49.32% Other Institutional Investors
11.35% ETFs
20.74% Public Companies and Individual Investors
The ownership structure of Ocular Therapeutix (OCUL) stock is a mix of institutional, retail, and individual investors. Approximately 70.42% of the company’s stock is owned by Institutional Investors, 8.84% is owned by Insiders, and 20.74% is owned by Public Companies and Individual Investors.
The ownership structure of Ocular Therapeutix (OCUL) stock is a mix of institutional, retail, and individual investors. Approximately 59.06% of the company’s stock is owned by Institutional Investors, 8.84% is owned by Insiders, and 11.35% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 04, 2025
Donald Notman
Cfo And Coo
xxxxxxxxxxxxx
$86839
Nov 27, 2024
xxxxxxxxxxxxx
$16326
Nov 27, 2024
Pravin Dugel
Executive Chairman, President And Ceo,director
xxxxxxxxxxxxx
$186327
Nov 27, 2024
xxxxxxxxxxxxx
$26561

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$896700

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,591,401Insider5.46%62,545,399
7,928,010Institution5.04%57,715,913
6,715,738Institution4.27%48,890,573
6,550,113Institution4.17%47,684,823
3,541,793Insider2.25%25,784,253
3,324,468Institution2.11%24,202,127
1,701,119Institution1.08%12,384,146
1,299,952Institution0.83%9,463,651
1,254,413Institution0.80%9,132,127
1,000,000Institution0.64%7,280,000

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,550,113Institution4.17%47,684,823
1,701,119Institution1.08%12,384,146
1,299,952Institution0.83%9,463,651
1,254,413Institution0.80%9,132,127
888,486Institution0.57%6,468,178
682,612Institution0.43%4,969,415
438,853Institution0.28%3,194,850
427,500Institution0.27%3,112,200
410,100Institution0.26%2,985,528
400,000Institution0.25%2,912,000

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,643,156Institution2.95%39,652,552
4,183,125Institution2.66%30,453,150
1,951,868Institution1.24%16,668,953
1,388,783Institution0.88%10,110,340
793,030Institution0.50%5,773,258
737,738Institution0.47%6,300,283
613,381Institution0.39%4,588,090
357,664Institution0.23%2,603,794
304,925Institution0.19%2,604,060
277,238Institution0.18%2,018,293

FAQ

Who Owns Ocular Therapeutix (OCUL)?
According to the latest TipRanks data, approximately 49.32% of the company's stock is held by institutional investors, 8.84% is held by insiders, and 20.74% is held by retail investors.
    What percentage of Ocular Therapeutix (OCUL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 49.32% of Ocular Therapeutix (OCUL) stock is held by institutional investors.
      What percentage of Ocular Therapeutix (OCUL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 20.74% of Ocular Therapeutix (OCUL) stock is held by retail investors.
        Who owns the most shares of Ocular Therapeutix (OCUL)?
        SUMMER ROAD LLC owns the most shares of Ocular Therapeutix (OCUL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis